Acesso livre
Acesso livre

Cardiologia

M-A de estudos randomizados | Colchicina e riscos de doença cardíaca coronariana.

4 Out, 2022 | 12:36h

Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials – Frontiers in Cardiovascular Medicine

Conteúdos relacionados:

M-A: Colchicine after percutaneous coronary intervention significantly reduces the risk of major adverse cardiovascular events in patients with symptomatic coronary artery disease.

Expert Analysis | Colchicine in acute coronary syndrome: when to commence?

M-A: Colchicine in patients with coronary artery disease – “colchicine reduces the risk of myocardial infarction and stroke, but has a higher rate of gastrointestinal upset with no influence on all‐cause mortality”.

Review: Colchicine and the heart.

M-A: Colchicine administration for percutaneous coronary intervention

M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease

Expert analysis: Efficacy and safety of colchicine in patients with chronic stable coronary disease

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome

#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

#AHA19 – [Abstract Only] Practice Changing? – Randomized Trial: Low-Dose Colchicine Improves Outcomes after Myocardial Infarction

Research: Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome

 

Seguimento de longo prazo de um estudo randomizado | Monoterapia com inibidor de P2Y12 vs. terapia antiplaquetária dupla (dual antiplatelet therapy – DAPT) após intervenção coronariana percutânea.

4 Out, 2022 | 12:34h

Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial – JAMA Cardiology (link para o resumo – $ para o texto completo)

Estudo original: Randomized Trials: Shorter Duration of Dual Antiplatelet Therapy May be an Option for Patients Undergoing Percutaneous Coronary Intervention

 

Comentário no Twitter

 

Estudo randomizado | Hipotermia induzida não melhorou a sobrevida ou os desfechos funcionais após parada cardíaca em ambiente hospitalar.

3 Out, 2022 | 12:58h

Temperature Control After In-Hospital Cardiac Arrest: A Randomized Clinical Trial – Circulation (gratuito por tempo limitado)

Conteúdos relacionados:

Hypothermic versus Normothermic Temperature Control after Cardiac Arrest – NEJM Evidence

ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (se o acesso a este link for pago, tente este)

Target temperature management following cardiac arrest: a systematic review and Bayesian meta-analysis – Critical Care

Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets – Intensive Care Medicine

Targeted Temperature Management for Cardiac Arrest Due to Non-shockable Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Frontiers in Medicine

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial – JAMA

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest – New England Journal of Medicine

 

Comentário no Twitter

 

Estudo | Histologia de placas e doença miocárdica na morte súbita coronariana.

3 Out, 2022 | 12:55h

Plaque histology and myocardial disease in sudden coronary death: the Fingesture study – European Heart Journal

 

Estudo de coorte | Fenótipos de imagens de ressonância magnética cardiovascular e desfechos de longo prazo em pacientes com suspeita de sarcoidose cardíaca.

3 Out, 2022 | 12:52h

Cardiovascular Magnetic Resonance Imaging Phenotypes and Long-term Outcomes in Patients With Suspected Cardiac Sarcoidosis – JAMA Cardiology (link para o resumo – $ para o texto completo)

Comentário: Cardiovascular magnetic resonance imaging phenotype with pathology-frequent late gadolinium enhancement associated with high-risk of ventricular arrhythmic and heart failure events – Physician’s Weekly

 

Comentário no Twitter

 

Estudo de coorte mostrou uma possível ligação entre adoçantes artificiais e doença cardíaca.

13 Set, 2022 | 12:07h

Comunicado de imprensa: Possible link between artificial sweeteners and heart disease – BMJ Newsroom

Estudo original: Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort – The BMJ

 

Desfechos de 5 anos de pacientes com dispositivos de assistência ventricular esquerda de levitação totalmente magnética vs. de fluxo axial no estudo randomizado MOMENTUM 3.

13 Set, 2022 | 11:57h

Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial – JAMA (gratuito por tempo limitado)

 

Comentário no Twitter

 

M-A de rede | Eficácia comparativa de terapias de redução de lípides adicionadas a máximas doses toleradas de estatinas na redução do LDL-colesterol.

13 Set, 2022 | 11:53h

Network Meta‐Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid‐Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low‐Density Lipoprotein Cholesterol – Journal of the American Heart Association

 

Estudo randomizado | Efeitos da administração do nicorandil no tamanho do infarto de pacientes com infarto do miocárdio com elevação do segmento ST submetidos a intervenção coronariana percutânea primária.

13 Set, 2022 | 11:52h

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial – Journal of the American Heart Association

 

Não adesão ao tratamento foi revelada por meio de medidas da concentração sérica de medicamentos anti-hipertensivos em 1/3 dos pacientes com hipertensão resistente previamente avaliados como aderentes ao tratamento.

13 Set, 2022 | 11:51h

Nonadherence by Serum Drug Analyses in Resistant Hypertension: 7‐Year Follow‐Up of Patients Considered Adherent by Directly Observed Therapy – Journal of the American Heart Association

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.